AT GOAL: Adopting Technology for Glucose Optimization and Lifestyle in Pregnancy
Continuous Glucose Monitoring in Pregnant Patients With Type 2 Diabetes, a Mixed Methods Approach
Sponsor: DexCom, Inc.
This NA trial investigates Pregnancy in Diabetic and Type2Diabetes and is currently completed. DexCom, Inc. leads this study, which shows 10 recorded versions since 2022 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Feb 2025 — Present [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jan 2025 — Feb 2025 [monthly]
Active Not Recruiting NA
-
Sep 2024 — Jan 2025 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Dec 2023 — Jul 2024 [monthly]
Recruiting NA
▶ Show 5 earlier versions
-
Apr 2023 — Dec 2023 [monthly]
Recruiting NA
-
Dec 2022 — Apr 2023 [monthly]
Recruiting NA
-
Sep 2022 — Dec 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jul 2022 — Sep 2022 [monthly]
Not Yet Recruiting NA
-
Jun 2022 — Jul 2022 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- DexCom, Inc.
- University of Wisconsin, Madison
For direct contact, visit the study record on ClinicalTrials.gov .